GENSANCT04947059
Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2022); last known: Recruiting
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Primary completion date: Oct 2024 to Oct 2025
- Study completion date: Oct 2025 to Oct 2026
- Start date changed from estimate of Oct 2021 to Dec 14, 2021
- Site details revised
Notable Primary endpoints revised (4)v2 Show 4 more changesShow less
- Primary completion date: Sep 2024 to Oct 2024
- Study completion date: Sep 2025 to Oct 2025
- Start date: Sep 2021 to Oct 2021
- Secondary endpoints revised (2)
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
Bladder cancer patients, who are treated with a transurethral resection of a bladder tumor, receive postoperatively, within 6 hours after the resection, an immediate single intravesical instillation with gemcitabine hydrochloride 2gr in 100ml of saline for 45-60 minutes and continuous saline irrigation for 24 hours
Bladder cancer patients, who are treated with a transurethral resection of a bladder tumor, receive postoperatively, within 6 hours after the resection, an immediate single intravesical instillation with epirubicine hydrochloride 50mg in 50ml of saline for 45-60 minutes and continuous saline irrigation for 24 hours
Drugs: Gemcitabine Hydrochloride combined with continuous saline irrigation, Epirubicin Hydrochloride combined with continuous saline irrigation
Sites
1 site in 1 country
- Urology Department, University of Thessaly, University Hospital of LarissaLarissa, Larissa/Thessaly, Greece